Control imoroni
Figure S1. ANT Expression in Affected Individual and Control Myoblast Cell Lines
Either undifferentiated or differentiated myoblasts from a control and individual #54027 were stained with antibodies against ANT (green), VDAC1 (red), myogenin (magenta) and with DAPI (blue). A reduced amount of ANT was found in differentiated but not in undifferentiated myoblasts in the affected individual. Myoblasts were grown on glass chamber slides under the conditions used for Western blotting. Cells were fixed in 4% neutral buffered formalin for 10 min, followed by heat induced epitope retrieval in antigen retrieval buffer containing 1 mM EDTA and 0.05% Tween 20 for 20 min at 95°C. Permeabilization was performed with phosphate-buffered saline (PBS pH 7.6) containing 0.1% Triton X-100 for 15 min. Sections were incubated for 1 h with anti-ANT antibody, washed three times in PBS containing 0.5% Tween 20 (PBS-T) and incubated 1 h with secondary donkey anti-mouse AlexaFluor488 and washed again three times in PBS-T. Afterwards slides were incubated with primary anti-myogenin and anti-VDAC1 antibodies and secondary anti donkey antimouse AlexaFluor647 and goat anti-rabbit AlexaFluor594. For immunofluorescence staining, the following antibodies were used: monoclonal mouse anti-ANT (1:100; mouse; MSA02, Mitosciences), anti-VDAC1 (1:400; rabbit; ab15895), monoclonal anti-myogenin (1:25; mouse; M3559, Dako).
Secondary AlexaFluor labelled antibodies were purchased from Invitrogen and diluted 1:1000. All antibodies were diluted in Dako antibody diluent with background reducing components (Dako). 
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